SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5dmr'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MJ2_C_SAMC2199_0 (PROTEIN (METHIONINE REPRESSOR))	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	5 / 12	ALA A 538 GLY A 525 GLU A 616 LEU A 552 PRO A 553	None	1.14A	1mj2C-5dmrA: undetectable 1mj2D-5dmrA: undetectable	1mj2C-5dmrA: 21.26 1mj2D-5dmrA: 21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MJO_C_SAMC200_0 (METHIONINE REPRESSOR)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	5 / 12	ALA A 538 GLY A 525 GLU A 616 LEU A 552 PRO A 553	None	1.19A	1mjoC-5dmrA: undetectable 1mjoD-5dmrA: undetectable	1mjoC-5dmrA: 21.26 1mjoD-5dmrA: 21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_P_CHDP4525_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE III)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.44A	1v54N-5dmrA: undetectable 1v54P-5dmrA: undetectable	1v54N-5dmrA: 15.89 1v54P-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.45A	2dysA-5dmrA: undetectable 2dysC-5dmrA: undetectable	2dysA-5dmrA: 15.89 2dysC-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_P_CHDP304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.37A	2dysN-5dmrA: undetectable 2dysP-5dmrA: undetectable	2dysN-5dmrA: 15.89 2dysP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_P_CHDP304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.44A	2dysN-5dmrA: undetectable 2dysP-5dmrA: undetectable	2dysN-5dmrA: 15.89 2dysP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.43A	2eijA-5dmrA: undetectable 2eijC-5dmrA: undetectable	2eijA-5dmrA: 15.89 2eijC-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.42A	2eikA-5dmrA: undetectable 2eikC-5dmrA: undetectable	2eikA-5dmrA: 15.89 2eikC-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.43A	2eikN-5dmrA: undetectable 2eikP-5dmrA: undetectable	2eikN-5dmrA: 15.89 2eikP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.46A	2eilA-5dmrA: undetectable 2eilC-5dmrA: undetectable	2eilA-5dmrA: 15.89 2eilC-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.43A	2eilN-5dmrA: undetectable 2eilP-5dmrA: undetectable	2eilN-5dmrA: 15.89 2eilP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_A_CHDA525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.40A	2eimA-5dmrA: undetectable 2eimC-5dmrA: undetectable	2eimA-5dmrA: 15.89 2eimC-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.41A	2eimN-5dmrA: undetectable 2eimP-5dmrA: undetectable	2eimN-5dmrA: 15.89 2eimP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.43A	2einA-5dmrA: undetectable 2einC-5dmrA: undetectable	2einA-5dmrA: 15.89 2einC-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.36A	2einN-5dmrA: undetectable 2einP-5dmrA: undetectable	2einN-5dmrA: 15.89 2einP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.42A	2einN-5dmrA: undetectable 2einP-5dmrA: undetectable	2einN-5dmrA: 15.89 2einP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XN7_A_T44A1355_1 (THYROXINE-BINDING GLOBULIN)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	5 / 10	ALA A 573 LEU A 509 LEU A 624 LEU A 570 LEU A 630	None	1.05A	2xn7A-5dmrA: undetectable 2xn7B-5dmrA: undetectable	2xn7A-5dmrA: 21.85 2xn7B-5dmrA: 11.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y69_A_CHDA1517_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.44A	2y69A-5dmrA: undetectable 2y69C-5dmrA: undetectable	2y69A-5dmrA: 15.89 2y69C-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.36A	2zxwN-5dmrA: undetectable 2zxwP-5dmrA: undetectable	2zxwN-5dmrA: 15.89 2zxwP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.43A	3abkA-5dmrA: undetectable 3abkC-5dmrA: undetectable	3abkA-5dmrA: 15.89 3abkC-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.43A	3abkN-5dmrA: undetectable 3abkP-5dmrA: undetectable	3abkN-5dmrA: 15.89 3abkP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.35A	3abmN-5dmrA: undetectable 3abmP-5dmrA: undetectable	3abmN-5dmrA: 15.89 3abmP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.46A	3abmN-5dmrA: undetectable 3abmP-5dmrA: undetectable	3abmN-5dmrA: 15.89 3abmP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG1_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.46A	3ag1A-5dmrA: undetectable 3ag1C-5dmrA: undetectable	3ag1A-5dmrA: 15.89 3ag1C-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG1_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.44A	3ag1N-5dmrA: undetectable 3ag1P-5dmrA: undetectable	3ag1N-5dmrA: 15.89 3ag1P-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_A_CHDA525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.45A	3ag2A-5dmrA: undetectable 3ag2C-5dmrA: undetectable	3ag2A-5dmrA: 15.89 3ag2C-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.39A	3ag2N-5dmrA: undetectable 3ag2P-5dmrA: undetectable	3ag2N-5dmrA: 15.89 3ag2P-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG2_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.45A	3ag2N-5dmrA: undetectable 3ag2P-5dmrA: undetectable	3ag2N-5dmrA: 15.89 3ag2P-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.44A	3ag3N-5dmrA: undetectable 3ag3P-5dmrA: undetectable	3ag3N-5dmrA: 15.89 3ag3P-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_C_CHDC525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.45A	3ag4A-5dmrA: undetectable 3ag4C-5dmrA: undetectable	3ag4A-5dmrA: 15.89 3ag4C-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.38A	3ag4N-5dmrA: undetectable 3ag4P-5dmrA: undetectable	3ag4N-5dmrA: 15.89 3ag4P-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_P_CHDP1525_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.44A	3ag4N-5dmrA: undetectable 3ag4P-5dmrA: undetectable	3ag4N-5dmrA: 15.89 3ag4P-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EIG_A_MTXA200_1 (DIHYDROFOLATE REDUCTASE)	5dmr	EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR SUBUNIT 1 REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus; Mus musculus)	5 / 12	ILE B 294 ALA A 591 LEU A 621 GLU B 398 TYR A 586	None	1.43A	3eigA-5dmrB: undetectable	3eigA-5dmrB: 21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ELZ_B_CHDB153_0 (ILEAL BILE ACID-BINDING PROTEIN)	5dmr	EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR SUBUNIT 1 (Mus musculus)	4 / 6	ILE B 319 THR B 308 PHE B 402 TYR B 290	None	1.19A	3elzB-5dmrB: undetectable	3elzB-5dmrB: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LSL_A_PZIA802_0 (GLUTAMATE RECEPTOR 2)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	3 / 3	ASP A 524 ASN A 649 SER A 526	None	0.91A	3lslA-5dmrA: undetectable 3lslD-5dmrA: undetectable	3lslA-5dmrA: 25.00 3lslD-5dmrA: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LSL_D_PZID802_0 (GLUTAMATE RECEPTOR 2)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	3 / 3	SER A 526 ASP A 524 ASN A 649	None	0.84A	3lslA-5dmrA: undetectable 3lslD-5dmrA: undetectable	3lslA-5dmrA: 25.00 3lslD-5dmrA: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PHN_A_ACTA108_0 (PROTEIN P-30)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	3 / 3	THR A 556 SER A 557 ARG A 560	None	0.83A	3phnA-5dmrA: undetectable	3phnA-5dmrA: 18.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JX1_F_CAMF502_0 (CAMPHOR 5-MONOOXYGENASE)	5dmr	EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR SUBUNIT 1 (Mus musculus)	4 / 4	TYR B 290 THR B 308 VAL B 322 ILE B 412	None	1.47A	4jx1F-5dmrB: undetectable	4jx1F-5dmrB: 19.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UDA_A_DEXA1985_2 (MINERALOCORTICOID RECEPTOR)	5dmr	EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR SUBUNIT 1 (Mus musculus)	4 / 6	LEU B 389 LEU B 326 THR B 308 VAL B 317	None	1.08A	4udaA-5dmrB: undetectable	4udaA-5dmrB: 18.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.38A	5b1aN-5dmrA: undetectable 5b1aP-5dmrA: undetectable	5b1aN-5dmrA: 15.89 5b1aP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.45A	5b1aN-5dmrA: undetectable 5b1aP-5dmrA: undetectable	5b1aN-5dmrA: 15.89 5b1aP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.37A	5b1bN-5dmrA: undetectable 5b1bP-5dmrA: undetectable	5b1bN-5dmrA: 15.89 5b1bP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.44A	5b1bN-5dmrA: undetectable 5b1bP-5dmrA: undetectable	5b1bN-5dmrA: 15.89 5b1bP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.39A	5b3sN-5dmrA: undetectable 5b3sP-5dmrA: undetectable	5b3sN-5dmrA: 15.89 5b3sP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_P_CHDP301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.44A	5b3sN-5dmrA: undetectable 5b3sP-5dmrA: undetectable	5b3sN-5dmrA: 15.89 5b3sP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.37A	5iy5A-5dmrA: undetectable 5iy5C-5dmrA: undetectable	5iy5A-5dmrA: 15.89 5iy5C-5dmrA: 22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.43A	5iy5A-5dmrA: undetectable 5iy5C-5dmrA: undetectable	5iy5A-5dmrA: 15.89 5iy5C-5dmrA: 22.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X19_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.38A	5x19N-5dmrA: undetectable 5x19P-5dmrA: undetectable	5x19N-5dmrA: 15.89 5x19P-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X19_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.44A	5x19N-5dmrA: undetectable 5x19P-5dmrA: undetectable	5x19N-5dmrA: 15.89 5x19P-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1F_P_CHDP305_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.41A	5x1fN-5dmrA: undetectable 5x1fP-5dmrA: undetectable	5x1fN-5dmrA: 15.89 5x1fP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NKN_C_CHDC301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.39A	6nknA-5dmrA: undetectable 6nknC-5dmrA: undetectable	6nknA-5dmrA: 15.89 6nknC-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMF_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.41A	6nmfN-5dmrA: undetectable 6nmfP-5dmrA: undetectable	6nmfN-5dmrA: 15.89 6nmfP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMF_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.45A	6nmfN-5dmrA: undetectable 6nmfP-5dmrA: undetectable	6nmfN-5dmrA: 15.89 6nmfP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_C_CHDC303_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.35A	6nmpA-5dmrA: undetectable 6nmpC-5dmrA: undetectable	6nmpA-5dmrA: 15.89 6nmpC-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_C_CHDC303_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 6	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.44A	6nmpA-5dmrA: undetectable 6nmpC-5dmrA: undetectable	6nmpA-5dmrA: 15.89 6nmpC-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_P_CHDP302_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	ASP A 524 THR A 523 TYR A 522 HIS A 592	None	1.38A	6nmpN-5dmrA: undetectable 6nmpP-5dmrA: undetectable	6nmpN-5dmrA: 15.89 6nmpP-5dmrA: 22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_P_CHDP302_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 3)	5dmr	REVERSE TRANSCRIPTASE/RIBONU CLEASE H P80 (Murine leukemia virus)	4 / 7	HIS A 592 ASP A 583 THR A 582 TYR A 581	None	1.47A	6nmpN-5dmrA: undetectable 6nmpP-5dmrA: undetectable	6nmpN-5dmrA: 15.89 6nmpP-5dmrA: 22.48

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1MJ2_C_SAMC2199_0","PROTEIN (METHIONINE REPRESSOR)","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",5,"ALA A 538;GLY A 525;GLU A 616;LEU A 552;PRO A 553","None","1.14A","1mj2C-5dmrA:undetectable;1mj2D-5dmrA:undetectable","1mj2C-5dmrA:21.26;1mj2D-5dmrA:21.26"],["1MJO_C_SAMC200_0","METHIONINE REPRESSOR","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",5,"ALA A 538;GLY A 525;GLU A 616;LEU A 552;PRO A 553","None","1.19A","1mjoC-5dmrA:undetectable;1mjoD-5dmrA:undetectable","1mjoC-5dmrA:21.26;1mjoD-5dmrA:21.26"],["1V54_P_CHDP4525_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE III","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.44A","1v54N-5dmrA:undetectable;1v54P-5dmrA:undetectable","1v54N-5dmrA:15.89;1v54P-5dmrA:22.48"],["2DYS_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.45A","2dysA-5dmrA:undetectable;2dysC-5dmrA:undetectable","2dysA-5dmrA:15.89;2dysC-5dmrA:22.48"],["2DYS_P_CHDP304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.37A","2dysN-5dmrA:undetectable;2dysP-5dmrA:undetectable","2dysN-5dmrA:15.89;2dysP-5dmrA:22.48"],["2DYS_P_CHDP304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.44A","2dysN-5dmrA:undetectable;2dysP-5dmrA:undetectable","2dysN-5dmrA:15.89;2dysP-5dmrA:22.48"],["2EIJ_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.43A","2eijA-5dmrA:undetectable;2eijC-5dmrA:undetectable","2eijA-5dmrA:15.89;2eijC-5dmrA:22.48"],["2EIK_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.42A","2eikA-5dmrA:undetectable;2eikC-5dmrA:undetectable","2eikA-5dmrA:15.89;2eikC-5dmrA:22.48"],["2EIK_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.43A","2eikN-5dmrA:undetectable;2eikP-5dmrA:undetectable","2eikN-5dmrA:15.89;2eikP-5dmrA:22.48"],["2EIL_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.46A","2eilA-5dmrA:undetectable;2eilC-5dmrA:undetectable","2eilA-5dmrA:15.89;2eilC-5dmrA:22.48"],["2EIL_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.43A","2eilN-5dmrA:undetectable;2eilP-5dmrA:undetectable","2eilN-5dmrA:15.89;2eilP-5dmrA:22.48"],["2EIM_A_CHDA525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.40A","2eimA-5dmrA:undetectable;2eimC-5dmrA:undetectable","2eimA-5dmrA:15.89;2eimC-5dmrA:22.48"],["2EIM_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.41A","2eimN-5dmrA:undetectable;2eimP-5dmrA:undetectable","2eimN-5dmrA:15.89;2eimP-5dmrA:22.48"],["2EIN_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.43A","2einA-5dmrA:undetectable;2einC-5dmrA:undetectable","2einA-5dmrA:15.89;2einC-5dmrA:22.48"],["2EIN_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.36A","2einN-5dmrA:undetectable;2einP-5dmrA:undetectable","2einN-5dmrA:15.89;2einP-5dmrA:22.48"],["2EIN_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.42A","2einN-5dmrA:undetectable;2einP-5dmrA:undetectable","2einN-5dmrA:15.89;2einP-5dmrA:22.48"],["2XN7_A_T44A1355_1","THYROXINE-BINDING GLOBULIN;THYROXINE-BINDING GLOBULIN","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",5,"ALA A 573;LEU A 509;LEU A 624;LEU A 570;LEU A 630","None","1.05A","2xn7A-5dmrA:undetectable;2xn7B-5dmrA:undetectable","2xn7A-5dmrA:21.85;2xn7B-5dmrA:11.52"],["2Y69_A_CHDA1517_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.44A","2y69A-5dmrA:undetectable;2y69C-5dmrA:undetectable","2y69A-5dmrA:15.89;2y69C-5dmrA:22.48"],["2ZXW_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.36A","2zxwN-5dmrA:undetectable;2zxwP-5dmrA:undetectable","2zxwN-5dmrA:15.89;2zxwP-5dmrA:22.48"],["3ABK_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.43A","3abkA-5dmrA:undetectable;3abkC-5dmrA:undetectable","3abkA-5dmrA:15.89;3abkC-5dmrA:22.48"],["3ABK_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.43A","3abkN-5dmrA:undetectable;3abkP-5dmrA:undetectable","3abkN-5dmrA:15.89;3abkP-5dmrA:22.48"],["3ABM_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.35A","3abmN-5dmrA:undetectable;3abmP-5dmrA:undetectable","3abmN-5dmrA:15.89;3abmP-5dmrA:22.48"],["3ABM_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.46A","3abmN-5dmrA:undetectable;3abmP-5dmrA:undetectable","3abmN-5dmrA:15.89;3abmP-5dmrA:22.48"],["3AG1_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.46A","3ag1A-5dmrA:undetectable;3ag1C-5dmrA:undetectable","3ag1A-5dmrA:15.89;3ag1C-5dmrA:22.48"],["3AG1_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.44A","3ag1N-5dmrA:undetectable;3ag1P-5dmrA:undetectable","3ag1N-5dmrA:15.89;3ag1P-5dmrA:22.48"],["3AG2_A_CHDA525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.45A","3ag2A-5dmrA:undetectable;3ag2C-5dmrA:undetectable","3ag2A-5dmrA:15.89;3ag2C-5dmrA:22.48"],["3AG2_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.39A","3ag2N-5dmrA:undetectable;3ag2P-5dmrA:undetectable","3ag2N-5dmrA:15.89;3ag2P-5dmrA:22.48"],["3AG2_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.45A","3ag2N-5dmrA:undetectable;3ag2P-5dmrA:undetectable","3ag2N-5dmrA:15.89;3ag2P-5dmrA:22.48"],["3AG3_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.44A","3ag3N-5dmrA:undetectable;3ag3P-5dmrA:undetectable","3ag3N-5dmrA:15.89;3ag3P-5dmrA:22.48"],["3AG4_C_CHDC525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.45A","3ag4A-5dmrA:undetectable;3ag4C-5dmrA:undetectable","3ag4A-5dmrA:15.89;3ag4C-5dmrA:22.48"],["3AG4_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.38A","3ag4N-5dmrA:undetectable;3ag4P-5dmrA:undetectable","3ag4N-5dmrA:15.89;3ag4P-5dmrA:22.48"],["3AG4_P_CHDP1525_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.44A","3ag4N-5dmrA:undetectable;3ag4P-5dmrA:undetectable","3ag4N-5dmrA:15.89;3ag4P-5dmrA:22.48"],["3EIG_A_MTXA200_1","DIHYDROFOLATE REDUCTASE","5dmr","EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR SUBUNIT 1;REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus;Mus musculus",5,"ILE B 294;ALA A 591;LEU A 621;GLU B 398;TYR A 586","None","1.43A","3eigA-5dmrB:undetectable","3eigA-5dmrB:21.24"],["3ELZ_B_CHDB153_0","ILEAL BILE ACID-BINDING PROTEIN","5dmr","EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR SUBUNIT 1","Mus musculus",4,"ILE B 319;THR B 308;PHE B 402;TYR B 290","None","1.19A","3elzB-5dmrB:undetectable","3elzB-5dmrB:22.35"],["3LSL_A_PZIA802_0","GLUTAMATE RECEPTOR 2","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",3,"ASP A 524;ASN A 649;SER A 526","None","0.91A","3lslA-5dmrA:undetectable;3lslD-5dmrA:undetectable","3lslA-5dmrA:25.00;3lslD-5dmrA:25.00"],["3LSL_D_PZID802_0","GLUTAMATE RECEPTOR 2","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",3,"SER A 526;ASP A 524;ASN A 649","None","0.84A","3lslA-5dmrA:undetectable;3lslD-5dmrA:undetectable","3lslA-5dmrA:25.00;3lslD-5dmrA:25.00"],["3PHN_A_ACTA108_0","PROTEIN P-30","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",3,"THR A 556;SER A 557;ARG A 560","None","0.83A","3phnA-5dmrA:undetectable","3phnA-5dmrA:18.34"],["4JX1_F_CAMF502_0","CAMPHOR 5-MONOOXYGENASE","5dmr","EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR SUBUNIT 1","Mus musculus",4,"TYR B 290;THR B 308;VAL B 322;ILE B 412","None","1.47A","4jx1F-5dmrB:undetectable","4jx1F-5dmrB:19.09"],["4UDA_A_DEXA1985_2","MINERALOCORTICOID RECEPTOR","5dmr","EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR SUBUNIT 1","Mus musculus",4,"LEU B 389;LEU B 326;THR B 308;VAL B 317","None","1.08A","4udaA-5dmrB:undetectable","4udaA-5dmrB:18.73"],["5B1A_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.38A","5b1aN-5dmrA:undetectable;5b1aP-5dmrA:undetectable","5b1aN-5dmrA:15.89;5b1aP-5dmrA:22.48"],["5B1A_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.45A","5b1aN-5dmrA:undetectable;5b1aP-5dmrA:undetectable","5b1aN-5dmrA:15.89;5b1aP-5dmrA:22.48"],["5B1B_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.37A","5b1bN-5dmrA:undetectable;5b1bP-5dmrA:undetectable","5b1bN-5dmrA:15.89;5b1bP-5dmrA:22.48"],["5B1B_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.44A","5b1bN-5dmrA:undetectable;5b1bP-5dmrA:undetectable","5b1bN-5dmrA:15.89;5b1bP-5dmrA:22.48"],["5B3S_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.39A","5b3sN-5dmrA:undetectable;5b3sP-5dmrA:undetectable","5b3sN-5dmrA:15.89;5b3sP-5dmrA:22.48"],["5B3S_P_CHDP301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.44A","5b3sN-5dmrA:undetectable;5b3sP-5dmrA:undetectable","5b3sN-5dmrA:15.89;5b3sP-5dmrA:22.48"],["5IY5_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.37A","5iy5A-5dmrA:undetectable;5iy5C-5dmrA:undetectable","5iy5A-5dmrA:15.89;5iy5C-5dmrA:22.66"],["5IY5_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.43A","5iy5A-5dmrA:undetectable;5iy5C-5dmrA:undetectable","5iy5A-5dmrA:15.89;5iy5C-5dmrA:22.66"],["5X19_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.38A","5x19N-5dmrA:undetectable;5x19P-5dmrA:undetectable","5x19N-5dmrA:15.89;5x19P-5dmrA:22.48"],["5X19_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.44A","5x19N-5dmrA:undetectable;5x19P-5dmrA:undetectable","5x19N-5dmrA:15.89;5x19P-5dmrA:22.48"],["5X1F_P_CHDP305_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.41A","5x1fN-5dmrA:undetectable;5x1fP-5dmrA:undetectable","5x1fN-5dmrA:15.89;5x1fP-5dmrA:22.48"],["6NKN_C_CHDC301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.39A","6nknA-5dmrA:undetectable;6nknC-5dmrA:undetectable","6nknA-5dmrA:15.89;6nknC-5dmrA:22.48"],["6NMF_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.41A","6nmfN-5dmrA:undetectable;6nmfP-5dmrA:undetectable","6nmfN-5dmrA:15.89;6nmfP-5dmrA:22.48"],["6NMF_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.45A","6nmfN-5dmrA:undetectable;6nmfP-5dmrA:undetectable","6nmfN-5dmrA:15.89;6nmfP-5dmrA:22.48"],["6NMP_C_CHDC303_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.35A","6nmpA-5dmrA:undetectable;6nmpC-5dmrA:undetectable","6nmpA-5dmrA:15.89;6nmpC-5dmrA:22.48"],["6NMP_C_CHDC303_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.44A","6nmpA-5dmrA:undetectable;6nmpC-5dmrA:undetectable","6nmpA-5dmrA:15.89;6nmpC-5dmrA:22.48"],["6NMP_P_CHDP302_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"ASP A 524;THR A 523;TYR A 522;HIS A 592","None","1.38A","6nmpN-5dmrA:undetectable;6nmpP-5dmrA:undetectable","6nmpN-5dmrA:15.89;6nmpP-5dmrA:22.48"],["6NMP_P_CHDP302_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 3","5dmr","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H P80","Murine leukemia virus",4,"HIS A 592;ASP A 583;THR A 582;TYR A 581","None","1.47A","6nmpN-5dmrA:undetectable;6nmpP-5dmrA:undetectable","6nmpN-5dmrA:15.89;6nmpP-5dmrA:22.48"]]